Selected research
Industry Research
Multiplex Molecular Diagnosis Technology Industry Research Report 2026
Market perspective
The global Multiplex Molecular Diagnosis Technology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Multiplex Molecular Diagnosis Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Multiplex Molecular Diagnosis Technology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Multiplex Molecular Diagnosis Technology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Multiplex Molecular Diagnosis Technology include Siemens, Hologic, Thermo Fisher Scientific, Koninklijke Philips N.V., NeuroLogica, Shimadzu Medical, GENERAL ELECTRIC, Sysmex and Canon, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Multiplex Molecular Diagnosis Technology market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Multiplex Molecular Diagnosis Technology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Multiplex Molecular Diagnosis Technology Market by Company
Siemens
Hologic
Thermo Fisher Scientific
Koninklijke Philips N.V.
NeuroLogica
Shimadzu Medical
GENERAL ELECTRIC
Sysmex
Canon
FUJIFILM Holdings
Bio-Rad Laboratories
Roche Diagnostics
Luminex Corporation
Abbott Laboratories
QIAGEN
Multiplex Molecular Diagnosis Technology Segment by Type
Real-time PCR
Nested PCR with Melt Curve Analysis
PCR with Low Density Microarray
PCR with Liquid Phase Bead Array
PCR with Electrochemical Detection
Multiplex Molecular Diagnosis Technology Segment by Application
Hospital
Outpatient Surgery Centre
Others
Multiplex Molecular Diagnosis Technology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multiplex Molecular Diagnosis Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Multiplex Molecular Diagnosis Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multiplex Molecular Diagnosis Technology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Multiplex Molecular Diagnosis Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Real-time PCR
- Nested PCR with Melt Curve Analysis
- PCR with Low Density Microarray
- PCR with Liquid Phase Bead Array
- PCR with Electrochemical Detection
Applications
- Hospital
- Outpatient Surgery Centre
- Others
Companies covered
- Siemens
- Hologic
- Thermo Fisher Scientific
- Koninklijke Philips N.V.
- NeuroLogica
- Shimadzu Medical
- GENERAL ELECTRIC
- Sysmex
- Canon
- FUJIFILM Holdings
- Bio-Rad Laboratories
- Roche Diagnostics
- Luminex Corporation
- Abbott Laboratories
- QIAGEN
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Multiplex Molecular Diagnosis Technology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Real-time PCR
- 2.2.3 Nested PCR with Melt Curve Analysis
- 2.2.4 PCR with Low Density Microarray
- 2.2.5 PCR with Liquid Phase Bead Array
- 2.2.6 PCR with Electrochemical Detection
- 2.3 Multiplex Molecular Diagnosis Technology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Outpatient Surgery Centre
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Multiplex Molecular Diagnosis Technology Breakdown Data by Type
- 3.1 Global Multiplex Molecular Diagnosis Technology Historic Market Size by Type (2021-2026)
- 3.2 Global Multiplex Molecular Diagnosis Technology Forecasted Market Size by Type (2027-2032)
4 Multiplex Molecular Diagnosis Technology Breakdown Data by Application
- 4.1 Global Multiplex Molecular Diagnosis Technology Historic Market Size by Application (2021-2026)
- 4.2 Global Multiplex Molecular Diagnosis Technology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Multiplex Molecular Diagnosis Technology Market Perspective (2021-2032)
- 5.2 Global Multiplex Molecular Diagnosis Technology Growth Trends by Region
- 5.2.1 Global Multiplex Molecular Diagnosis Technology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Multiplex Molecular Diagnosis Technology Historic Market Size by Region (2021-2026)
- 5.2.3 Multiplex Molecular Diagnosis Technology Forecasted Market Size by Region (2027-2032)
- 5.3 Multiplex Molecular Diagnosis Technology Market Dynamics
- 5.3.1 Multiplex Molecular Diagnosis Technology Industry Trends
- 5.3.2 Multiplex Molecular Diagnosis Technology Market Drivers
- 5.3.3 Multiplex Molecular Diagnosis Technology Market Challenges
- 5.3.4 Multiplex Molecular Diagnosis Technology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Multiplex Molecular Diagnosis Technology Players by Revenue
- 6.1.1 Global Top Multiplex Molecular Diagnosis Technology Players by Revenue (2021-2026)
- 6.1.2 Global Multiplex Molecular Diagnosis Technology Revenue Market Share by Players (2021-2026)
- 6.2 Global Multiplex Molecular Diagnosis Technology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Multiplex Molecular Diagnosis Technology Head Office and Area Served
- 6.4 Global Multiplex Molecular Diagnosis Technology Players, Product Type & Application
- 6.5 Global Multiplex Molecular Diagnosis Technology Manufacturers Established Date
- 6.6 Global Multiplex Molecular Diagnosis Technology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Multiplex Molecular Diagnosis Technology Market Size (2021-2032)
- 7.2 North America Multiplex Molecular Diagnosis Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Multiplex Molecular Diagnosis Technology Market Size by Country (2021-2026)
- 7.4 North America Multiplex Molecular Diagnosis Technology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Multiplex Molecular Diagnosis Technology Market Size (2021-2032)
- 8.2 Europe Multiplex Molecular Diagnosis Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Multiplex Molecular Diagnosis Technology Market Size by Country (2021-2026)
- 8.4 Europe Multiplex Molecular Diagnosis Technology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Multiplex Molecular Diagnosis Technology Market Size (2021-2032)
- 9.2 Asia-Pacific Multiplex Molecular Diagnosis Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Multiplex Molecular Diagnosis Technology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Multiplex Molecular Diagnosis Technology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Multiplex Molecular Diagnosis Technology Market Size (2021-2032)
- 10.2 South America Multiplex Molecular Diagnosis Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Multiplex Molecular Diagnosis Technology Market Size by Country (2021-2026)
- 10.4 South America Multiplex Molecular Diagnosis Technology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Multiplex Molecular Diagnosis Technology Market Size (2021-2032)
- 11.2 Middle East & Africa Multiplex Molecular Diagnosis Technology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Multiplex Molecular Diagnosis Technology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Multiplex Molecular Diagnosis Technology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Siemens
- 12.1.1 Siemens Company Information
- 12.1.2 Siemens Business Overview
- 12.1.3 Siemens Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.1.4 Siemens Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.1.5 Siemens Recent Developments
- 12.2 Hologic
- 12.2.1 Hologic Company Information
- 12.2.2 Hologic Business Overview
- 12.2.3 Hologic Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.2.4 Hologic Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.2.5 Hologic Recent Developments
- 12.3 Thermo Fisher Scientific
- 12.3.1 Thermo Fisher Scientific Company Information
- 12.3.2 Thermo Fisher Scientific Business Overview
- 12.3.3 Thermo Fisher Scientific Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.3.4 Thermo Fisher Scientific Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.3.5 Thermo Fisher Scientific Recent Developments
- 12.4 Koninklijke Philips N.V.
- 12.4.1 Koninklijke Philips N.V. Company Information
- 12.4.2 Koninklijke Philips N.V. Business Overview
- 12.4.3 Koninklijke Philips N.V. Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.4.4 Koninklijke Philips N.V. Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.4.5 Koninklijke Philips N.V. Recent Developments
- 12.5 NeuroLogica
- 12.5.1 NeuroLogica Company Information
- 12.5.2 NeuroLogica Business Overview
- 12.5.3 NeuroLogica Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.5.4 NeuroLogica Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.5.5 NeuroLogica Recent Developments
- 12.6 Shimadzu Medical
- 12.6.1 Shimadzu Medical Company Information
- 12.6.2 Shimadzu Medical Business Overview
- 12.6.3 Shimadzu Medical Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.6.4 Shimadzu Medical Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.6.5 Shimadzu Medical Recent Developments
- 12.7 GENERAL ELECTRIC
- 12.7.1 GENERAL ELECTRIC Company Information
- 12.7.2 GENERAL ELECTRIC Business Overview
- 12.7.3 GENERAL ELECTRIC Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.7.4 GENERAL ELECTRIC Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.7.5 GENERAL ELECTRIC Recent Developments
- 12.8 Sysmex
- 12.8.1 Sysmex Company Information
- 12.8.2 Sysmex Business Overview
- 12.8.3 Sysmex Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.8.4 Sysmex Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.8.5 Sysmex Recent Developments
- 12.9 Canon
- 12.9.1 Canon Company Information
- 12.9.2 Canon Business Overview
- 12.9.3 Canon Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.9.4 Canon Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.9.5 Canon Recent Developments
- 12.10 FUJIFILM Holdings
- 12.10.1 FUJIFILM Holdings Company Information
- 12.10.2 FUJIFILM Holdings Business Overview
- 12.10.3 FUJIFILM Holdings Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.10.4 FUJIFILM Holdings Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.10.5 FUJIFILM Holdings Recent Developments
- 12.11 Bio-Rad Laboratories
- 12.11.1 Bio-Rad Laboratories Company Information
- 12.11.2 Bio-Rad Laboratories Business Overview
- 12.11.3 Bio-Rad Laboratories Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.11.4 Bio-Rad Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.11.5 Bio-Rad Laboratories Recent Developments
- 12.12 Roche Diagnostics
- 12.12.1 Roche Diagnostics Company Information
- 12.12.2 Roche Diagnostics Business Overview
- 12.12.3 Roche Diagnostics Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.12.4 Roche Diagnostics Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.12.5 Roche Diagnostics Recent Developments
- 12.13 Luminex Corporation
- 12.13.1 Luminex Corporation Company Information
- 12.13.2 Luminex Corporation Business Overview
- 12.13.3 Luminex Corporation Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.13.4 Luminex Corporation Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.13.5 Luminex Corporation Recent Developments
- 12.14 Abbott Laboratories
- 12.14.1 Abbott Laboratories Company Information
- 12.14.2 Abbott Laboratories Business Overview
- 12.14.3 Abbott Laboratories Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.14.4 Abbott Laboratories Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.14.5 Abbott Laboratories Recent Developments
- 12.15 QIAGEN
- 12.15.1 QIAGEN Company Information
- 12.15.2 QIAGEN Business Overview
- 12.15.3 QIAGEN Revenue in Multiplex Molecular Diagnosis Technology Business (2021-2026)
- 12.15.4 QIAGEN Multiplex Molecular Diagnosis Technology Product Portfolio
- 12.15.5 QIAGEN Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst